Several animal experiments have shown that NKX2.5 may be involved in the pathogenesis of embryonic congenital heart disease caused by gestational diabetes and that in a rat model, the expression of NKX2.5 decreased during heart development in foetuses of mothers with gestational diabetes [12–14]. Here, NKX2-5 is linked to congenital heart disease.